Aligos Therapeutics, Inc.

Historical 13F Holders

Symbol
ALGS
CUSIP
01626L105
All holders as of
Q4 2024
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2024 Q4 1 80.0 $3.19 k
2024 Q2 54 47.3 M $16.6 M
2024 Q1 56 46.2 M $45.3 M
2023 Q4 44 45.4 M $30.1 M
2023 Q3 37 25.7 M $19.2 M
2023 Q2 43 26.3 M $25.5 M
2023 Q1 49 27.3 M $23.9 M
2022 Q4 43 26.6 M $25.3 M
2022 Q3 53 27.6 M $30.4 M
2022 Q2 61 29.8 M $36.0 M
2022 Q1 79 31.8 M $68.4 M
2021 Q4 73 32.9 M $390 M
2021 Q3 69 31.2 M $484 M
2021 Q2 58 27.0 M $550 M
2021 Q1 53 27.0 M $612 M
2020 Q4 52 27.3 M $749 M